on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
San Francisco-based Jaguar Health, Inc. (NASDAQ:JAGX) announced today that its founder, president, and CEO, Lisa Conte, will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference. The event will be held from September 9-11, 2024.
Conte will offer an on-demand virtual presentation accessible starting at 7:00 AM Eastern on Monday, September 9, 2024. The conference will take place both virtually and in-person at Lotte New York Palace, New York City.
Jaguar Health focuses on developing proprietary prescription medicines derived from plants for treating gastrointestinal distress in humans and animals. Its subsidiaries, Napo Pharmaceuticals and Napo Therapeutics, work on commercializing these medicines and expanding their availability in Europe. Magdalena Biosciences focuses on mental health treatments derived from plants.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news